Cyclic Adenosine Monophosphate Activates Retinal Apolipoprotein A1 Expression and Inhibits Myopic Eye Growth

Rachel Ka Man Chun1, Sze Wan Shan1, Thomas Chuen Lam1

  • 1Laboratory of Experimental Optometry, Centre for Myopia Research, School of Optometry, The Hong Kong Polytechnic University, Hong Kong, Hong Kong Special Administrative Region of China.

Abstract

Insights

Cyclic adenosine monophosphate (cAMP) analogue 8-Bromo-cAMP inhibited myopia development in chicks. Increased retinal ApoA1 in treated and hyperopic eyes suggests a link between ApoA1 and cAMP in eye growth regulation.

Area of Science:

  • Ophthalmology
  • Molecular Biology
  • Developmental Biology

Background:

  • Apolipoprotein A1 (ApoA1) is known to inhibit myopia development.
  • The mechanism by which ApoA1 influences myopia is not fully understood.
  • ApoA1 interacts with cyclic adenosine monophosphate (cAMP) in various cellular contexts.

Purpose of the Study:

  • To investigate the potential role of the ApoA1-cAMP interaction in the development of myopia.
  • To determine if modulating cAMP levels affects myopia progression and ApoA1 expression in the retina.

Main Methods:

  • Chicks received intravitreal injections of 8-Bromo-cAMP (8-Br-cAMP), a nonmetabolizable cAMP analogue.
  • Lens-induced myopia was created using -10 diopter lenses.
  • Retinal levels of cAMP and ApoA1 were measured in chicks exposed to myopic, hyperopic, or plano lenses with or without 8-Br-cAMP treatment.

Main Results:

  • 8-Br-cAMP significantly inhibited the development of lens-induced myopia.
  • A higher concentration of 8-Br-cAMP (1 mM) increased retinal ApoA1 expression.
  • Elevated retinal cAMP and ApoA1 levels were observed specifically in hyperopic eyes.

Conclusions:

  • 8-Bromo-cAMP effectively prevents myopia development in a chick model.
  • The findings suggest a significant interplay between ApoA1 and cAMP in the regulation of eye growth.
  • This interaction may represent a novel therapeutic target for myopia control.

Related Concept Videos

cAMP-dependent Protein Kinase Pathways01:25

cAMP-dependent Protein Kinase Pathways

Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
9.2K
GPCRs Regulate Adenylyl Cylase Activity01:09

GPCRs Regulate Adenylyl Cylase Activity

Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of...
8.2K
Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
1.1K